Doxycycline for 14 days
Phase 2Small molecule
Doxycycline for 14 days is one of 6 small molecule programs targeting Syphilis. It is currently in Phase 2.
1
Indications
2
Total Trials
2
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
8 competitors in Syphilis
#DrugCompanyPhaseTrials
1Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Rocephin
CConrado Roberto Hoffmann Filho
Approved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Phase 3
Suprax
WWyeth-Lederle Vaccines
Approved
Doxycycline for 14 days
UUniversity of Washington
Phase 2
Ceftriaxone Sodium
PfizerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Doxycycline for 14 days. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- UUniversity of Washington